Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2025-04-23 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
《债务融资工具信息披露事务管理办法》
Regulatory Filings Classification · 95% confidence The document is a detailed internal management procedure for disclosure of debt financing instrument information by the company. It outlines principles, types of reports (annual, semi-annual, quarterly, and interim), disclosure timelines, major events requiring disclosure, and internal approval processes. It does not contain actual financial statements or results but rather sets rules and guidelines for information disclosure related to debt financing tools. It is not an announcement, transcript, or report of financial results but a governance and procedural document related to disclosure management. Therefore, it fits best under Regulatory Filings (RNS) as a compliance and procedural document that does not fit other specific categories.
2025-04-23 Chinese
内部控制审计报告
Regulatory Filings
2025-04-23 Chinese
审计委员会对会计师事务所履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a report from the Audit Committee regarding the supervision of the accounting firm Tianzhi International for the 2024 annual audit. It discusses the qualifications, audit scope, communication with auditors, and evaluation of the audit process for the 2024 annual report. The document is focused on the audit committee's oversight and the audit firm's performance rather than the full annual report itself. It is a standalone audit-related report describing the audit firm's role and the committee's supervision, which fits the definition of an Audit Report / Information (AR). The document length is 2064 characters, which is relatively short but contains substantive content about audit supervision, not just an announcement or certification. Therefore, it should be classified as AR rather than RPA or RNS. FY 2024
2025-04-23 Chinese
关于2024年度利润分配预案公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from the company regarding the 2024 annual profit distribution plan, including details on cash dividends per share, total dividend amounts, and the approval process by the board of directors, supervisory board, and independent directors. It includes specific dividend amounts, references to the audited net profit, and mentions that the plan will be submitted to the 2024 annual shareholders meeting for approval. The document is relatively short (2900 characters) and primarily serves to inform shareholders about the dividend distribution proposal rather than presenting a full financial report or detailed financial statements. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a report publication announcement or regulatory filing. Therefore, the correct classification is DIV with high confidence.
2025-04-23 Chinese
年度关联方资金占用专项审计报告
Regulatory Filings
2025-04-23 Chinese
2025年年度预算报告
Management Reports Classification · 95% confidence The document is titled '2025 Annual Financial Budget Report' and contains detailed budget planning information for the year 2025, including operating income targets, investment budget, and financing budget references. It explicitly states it is an internal management control indicator and not a profit forecast. The document length is short (833 characters) and it does not contain actual financial statements or results, but rather a budget plan. It also references other announcements for financing plans, indicating this is a planning document rather than a report of actual financial performance. This fits best with a Management Reports (MDA) classification, as it provides management's detailed explanation of financial plans and outlook rather than actual results or regulatory filings. It is not an Annual Report (10-K) or Interim Report (IR) because it lacks actual financial data and results. It is not a Regulatory Filing (RNS) because it is a substantive budget report, not a certification or announcement. Therefore, the best classification is MDA with high confidence.
2025-04-23 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.